Allarity Therapeutics, Inc. announced a private placement of a senior convertible promissory note at a principal amount of $660,000 issued at a discount of 10% for the gross proceeds of $600,000 on March 14, 2024. The note will have a coupon rate of 8% and will be convertible into common shares of the company at a conversion price of $0.3501 per share. The notes will be matured on March 14, 2025.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | -5.48% | -2.82% | -87.48% |
Apr. 15 | Top Premarket Gainers | MT |
Apr. 12 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.48% | 451K | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Allarity Therapeutics, Inc. announced that it has received $0.6 million in funding